Trinity Biotech | TRIB - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Abbott USD 29.64B 19.74B 2026-03
Bayer EUR 31.16B 480M 2026-06
Bio-Rad Laboratories USD 803M 100K 2026-06
EDAP TMS EUR 17.6M 16.6M 2026-03
J&J USD 37.34B 183M 2026-06
Mesa Laboratories USD 104.2M 104.3M 2024-09
OraSure Technologies USD 100K 17K 2025-12
Plus Therapeutics USD 3.79M 322K 2022-12
Roche Holding CHF 25.22B 2.21B 2026-06
Siemens EUR 41.32B 199M 2026-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Tosoh JPY 96.02B 11.78B 2026-06
Trinity Biotech USD 16.33M 98.53M 2025-12
Veracyte USD 0 0 2025-03